![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Sarshika Pharmachem LLP, a prominent pharmaceutical entity in India, has unveiled plans to construct a cutting-edge Bulk Drugs Intermediates Manufacturing Unit (BDIMU) in Vasanthanarasapura, Tumakuru, Karnataka, marking a significant investment of 15.4 crores.
This innovative venture serves as a pivotal catalyst for the nation's pharmaceutical sector, focusing on the production of vital intermediates crucial for the synthesis of life-saving medications like paracetamol, ibuprofen, and metformin, catering to both domestic and global markets.
Embracing an environmentally conscious approach, Sarshika Pharmachem LLP is dedicated to sustainability, integrating eco-friendly technologies, energy-efficient measures, and robust waste management strategies within the BDIMU to minimize its ecological footprint and foster responsible manufacturing practices.
As on December 2023, The project is now in the stage of receiving approvals. The project has received all necessary clearances. By the end of the year 2023, development on the project will have begun.
News by Rahul Yelligetti
